Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Advancing combination drug development through quantitative medicine

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Presentation
  • By: ROMERO, Klaus (Critical Path Institute, Clinical Pharmacology and Quantitative Medicine, Tucson, United States)
  • Co-author(s): Klaus Romero: Clinical Pharmacology and Quantitative Medicine, Critical Path Institute, Tucson, United States
    Debra Hanna: Critical Path to TB Drug Regimens (CPTR) Initiative, Critical Path Institute, Tucson, United States
  • Abstract:

    The development of novel tuberculosis (TB) multi-drug regimens that are more efficacious and of shorter duration requires a robust drug development pipeline. Advances in quantitative modeling and simulation can be used to maximize the utility of patient-level data from prior and contemporary clinical trials, thus optimizing study design for

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses